LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis

Huai-Bin Hu,Zeng-Qing Song,Guang-Ping Song,Sen Li,Hai-Qing Tu,Min Wu,Yu-Cheng Zhang,Jin-Feng Yuan,Ting-Ting Li,Pei-Yao Li,Yu-Ling Xu,Xiao-Lin Shen,Qiu-Ying Han,Ai-Ling Li,Tao Zhou,Jerold Chun,Xue-Min Zhang,Hui-Yan Li
DOI: https://doi.org/10.1038/s41467-021-20986-y
IF: 16.6
2021-01-01
Nature Communications
Abstract:Dynamic assembly and disassembly of primary cilia controls embryonic development and tissue homeostasis. Dysregulation of ciliogenesis causes human developmental diseases termed ciliopathies. Cell-intrinsic regulatory mechanisms of cilia disassembly have been well-studied. The extracellular cues controlling cilia disassembly remain elusive, however. Here, we show that lysophosphatidic acid (LPA), a multifunctional bioactive phospholipid, acts as a physiological extracellular factor to initiate cilia disassembly and promote neurogenesis. Through systematic analysis of serum components, we identify a small molecular—LPA as the major driver of cilia disassembly. Genetic inactivation and pharmacological inhibition of LPA receptor 1 (LPAR1) abrogate cilia disassembly triggered by serum. The LPA-LPAR-G-protein pathway promotes the transcription and phosphorylation of cilia disassembly factors-Aurora A, through activating the transcription coactivators YAP/TAZ and calcium/CaM pathway, respectively. Deletion of Lpar1 in mice causes abnormally elongated cilia and decreased proliferation in neural progenitor cells, thereby resulting in defective neurogenesis. Collectively, our findings establish LPA as a physiological initiator of cilia disassembly and suggest targeting the metabolism of LPA and the LPA pathway as potential therapies for diseases with dysfunctional ciliogenesis.
What problem does this paper attempt to address?